Industry Analysis & Industry Trends
Thin film drug manufacturers have experienced rapid revenue growth over the past five years, and this trend is expected to continue over the five years to 2019 as the patent cliff enables more generic drugs to enter the market. Further, over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments.... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Thin Film Drug Manufacturing industry is currently in the growth stage of its life cycle. During the ten years to 2019, industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 13.6%. Comparatively, US GDP is anticipated to rise at an average annual rate of 2.5% during the ten-year period. Due to relatively new advent of thin film technology, the industry is characterized by strong growth, in line with many manufacturers expanding their thin film drug pipeline.
While many thin film drug manufacturers have focused on the over-the-counter (OTC) market over the past five years, more thin film drugs will be offered as prescription drugs, thus providing a boon for the industry... purchase to read more